Stocks›Healthcare
WatchAlert

Fredun Pharmaceuticals Limited

FREDUN · BSE · Healthcare · As of 8 Nov 2026
₹1,521.40
+₹48.80 (+3.31%)(1D)
₹454.0552 Week Range₹1,665.00
Market Cap
₹486.81 Cr
P/E (Sector)
67.1 (32.3)
P/B Ratio
—
Dividend Yield
0.02%
ROE
1.9%
Debt / Equity
—
Anvest Score
24/100
  • Valuation
    0
  • Quality
    8
  • Growth
    18
  • Health
    27
  • Momentum
    93
Loading company profile…

Fundamentals

P/E Ratio (TTM)
67.11
Sector median P/E
32.29
P/B Ratio
—
Sector median P/B
4.4
EPS (TTM)
₹22.67
Market Cap
₹486.81 Cr
Dividend Yield
0.02%
ROE
1.92%
ROCE
2.06%
Profit Margin
5.2%
Loading technical indicators…
Loading financial statement…
Loading shareholding…
Loading filings…

Fredun Pharmaceuticals Limited FAQs

3 topics
Expand
What does the Fredun Pharmaceuticals Limited (FREDUN) stock page cover?
Fredun Pharmaceuticals Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.
What are the current headline metrics for FREDUN?
Fredun Pharmaceuticals Limited is currently shown with a delayed price near ₹1,521.4, P/E 67.11, and ROE 1.92%.
Does the FREDUN page provide investment advice?
No. The FREDUN page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.
Keep exploring

Related insights